Literature DB >> 29509234

The mechanisms of β-catenin on keloid fibroblast cells proliferation and apoptosis.

Z-Y Chen1, X-F Yu, J-Q Huang, D-L Li.   

Abstract

OBJECTIVE: To investigate the role of β-catenin siRNA on proliferation and apoptosis of keloid fibroblast cell. PATIENTS AND METHODS: Real-time polymerase chain reaction (RT-PCR) and Western blot were performed to monitor the mRNA and protein expression levels of β-catenin in pathological scar tissue and adjacent normal tissue. Human keloid fibroblast cells (KFB) were isolated from the keloid's tissue by enzyme digestion assay and identified by immunocytochemistry assay. Keloid fibroblast cell lines in vitro were transfected with 3 pairs of specific β-catenin small interfering RNA (siRNA); RT-PCR and Western blot were performed to identify the best siRNA. The proliferation and apoptosis of KFB transfected with β-catenin were estimated by MTT 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay and flow cytometry (FCM). In addition, the expression levels of Bcl-2, p53, and active-caspase-3 were detected by Western blot.
RESULTS: The RT-PCR and Western blot assay results showed that the expression levels of β-catenin mRNA and protein in pathological scar tissue were significantly higher than those in adjacent normal tissue (p<0.05). KFB were successfully separated from human pathological scar tissue, and immunofluorescence staining results showed that cells were spindle and positively stained with vimentin. The β-catenin siRNA2 remarkably inhibited the expression of β-catenin at mRNA and proteins levels in the human keloid fibroblasts. Compared with the control group, cell proliferation was decreased, and apoptotic rate was increased in β-catenin siRNA2 group.
CONCLUSIONS: Knockdown of β-catenin significantly decreased the proliferation and increased apoptosis of KFB, which could inhibit the formation of pathological scar.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29509234     DOI: 10.26355/eurrev_201802_14366

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

Review 1.  Advances in the pathogenesis and clinical application prospects of tumor biomolecules in keloid.

Authors:  Yijun Xia; Youbin Wang; Mengjie Shan; Yan Hao; Hao Liu; Qiao Chen; Zhengyun Liang
Journal:  Burns Trauma       Date:  2022-06-25

2.  Adipose-derived stem cells inhibit dermal fibroblast growth and induce apoptosis in keloids through the arachidonic acid-derived cyclooxygenase-2/prostaglandin E2 cascade by paracrine.

Authors:  Jinxiu Yang; Shiyi Li; Leren He; Minliang Chen
Journal:  Burns Trauma       Date:  2021-09-11

3.  Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-β1/Smad Signalling Pathway.

Authors:  Hui Ma; Xingwu Duan; Runtian Zhang; Hang Li; Yang Guo; Ye Tian; Min Huang; Guangshan Chen; Zi Wang; Lingling Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-15       Impact factor: 2.650

4.  Alpinetin Suppresses Effects of TGF-β1 on Stimulating the Production and Organization of Fibrotic Markers in Human Primary Dermal Fibroblasts.

Authors:  Nitwara Wikan; Saranyapin Potikanond; Wutigri Nimlamool
Journal:  Cells       Date:  2022-09-01       Impact factor: 7.666

5.  BTXA regulates the epithelial-mesenchymal transition and autophagy of keloid fibroblasts via modulating miR-1587/miR-2392 targeted ZEB2.

Authors:  Zhanying Hou; Feixiang Fan; Po Liu
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.